Clover Health Investments, Corp.

NasdaqGS CLOV

Clover Health Investments, Corp. EBIT Margin for the Trailing 12 Months (TTM) ending September 30, 2024: -6.13%

Clover Health Investments, Corp. EBIT Margin is -6.13% for the Trailing 12 Months (TTM) ending September 30, 2024, a 40.65% change year over year. EBIT ratio is the ratio of EBIT to revenue, measuring a company's operating profitability without considering non-operating income or expenses.
  • Clover Health Investments, Corp. EBIT Margin for the Trailing 12 Months (TTM) ending September 30, 2023 was -10.32%, a 29.29% change year over year.
  • Clover Health Investments, Corp. EBIT Margin for the Trailing 12 Months (TTM) ending September 30, 2022 was -14.60%, a 58.23% change year over year.
  • Clover Health Investments, Corp. EBIT Margin for the Trailing 12 Months (TTM) ending September 30, 2021 was -34.95%, a -182.12% change year over year.
  • Clover Health Investments, Corp. EBIT Margin for the Trailing 12 Months (TTM) ending September 30, 2020 was -12.39%.
Key data
Date EBIT Margin EPS (Basic) EPS (Diluted) Shares (Basic, Weighted)
Market news
Loading...
NasdaqGS: CLOV

Clover Health Investments, Corp.

CEO Mr. Andrew Toy
IPO Date June 12, 2020
Location United States
Headquarters 725 Cool Springs Blvd
Employees 552
Sector Health Care
Industries
Description

Clover Health Investments, Corp. operates as a medicare advantage insurer in the United States. The company through its Clover Assistant, a software platform that provides preferred provider organization and health maintenance organization health plans for medicare-eligible consumers. It also focuses on non-insurance businesses. Clover Health Investments, Corp. was incorporated in 2014 and is based in Franklin, Tennessee.

Similar companies

SKLZ

Skillz Inc.

USD 5.47

0.37%

SNDL

SNDL Inc.

USD 1.80

0.00%

FUBO

fuboTV Inc.

USD 3.81

-14.38%

StockViz Staff

January 15, 2025

Any question? Send us an email